MAZE THERAPEUTICS, INC. (MAZE)

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Oct 2, 2026 · Director, Chief Executive Officer Coloma Jason V sold 34.50K shares at $27.02/share ($932.3K)

Director, Chief Executive Officer Coloma Jason V sold 34.50K shares at $27.02/share ($932.3K)

xslF345X06/form4-10022026_081010.xml

xslF345X06/form4-10022026_081010.xmlSEC.gov

Graphics and non-inline formats (not embedded below).